ST Pharm Co.,ltd.

Korea, Republic of, Manufacture of pharmaceutical preparations

ST Pharm Co.,ltd. reported location-based Scope 2 emissions of 25,724 tCO2e for 2024, up 7.9% from 23,848 tCO2e in 2023. [1] p. 93 It reported Scope 3 emissions of 47,787 tCO2e for 2024, down 4.2% from 49,884 tCO2e in 2023. [1] p. 93

Legal name: ST PHARM CO.,LTD.
Headquarters: Korea, Republic of
Industry: Manufacture of pharmaceutical preparations (NACE 21.20)
Website: stpharm.co.kr
ISIN: KR7237690003
Documents read: 1
Figures shown: 9, all with a page citation

01 / Emissions

Greenhouse gas emissions

Tonnes of CO2 equivalent, as the company reported them. Each figure links to the page of the document it was read from. When a later report restates an earlier year, the later report is shown.

ST Pharm Co.,ltd. greenhouse gas emissions by scope, tCO2e
Metric	2022	2023	2024	Latest change
Scope 2, location-based	21,089[1] p. 93	23,848[1] p. 93	25,724[1] p. 93	up 7.9% vs 2023
Scope 3, total	46,384[1] p. 93	49,884[1] p. 93	47,787[1] p. 93	down 4.2% vs 2023

Scope 3 by category (1 reported)

ST Pharm Co.,ltd. Scope 3 emissions by category, tCO2e
Metric	2022	2023	2024	Latest change
3.1 Purchased goods and services	36,762[1] p. 93	39,635[1] p. 93	36,826[1] p. 93	down 7.1% vs 2023

02 / Targets

Targets and initiatives

Memberships and disclosures

CDP: Disclosed to CDP on climate change Register snapshot 2026-08-07. Source: CDP register

03 / Certifications

Certifications and labels

None found on the public certification registers we have matched to this company so far.

04 / Sources

Documents we read

Sustainability report with data through 2024, 117 pages. Published by ST Pharm Co.,ltd.. Entity check passed: the document names this company as the reporting entity.

Profile built 2026-11-15. Read how we collect and check this data.